Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01810484 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT01810484 is a NA study that has completed, run by Ulthera. The registered enrollment target is 14 participants.
The verdict
NCT01810484, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
Up to 20 subjects will be enrolled. Enrolled subjects will receive one of three study treatments in the abdominal region: Ultherapy® only, Ultherapy® and CO2 laser treatment, or CO2 laser treatment only. Follow-up visit will occur at 14, 90 and 180 days post-treatment. Study images will be obtained pre-treatment, approximately 30 minutes post-treatment, and at each follow-up visit.
Interventions
- DEVICE Ultherapy® treatment only
- DEVICE Ultherapy® treatment and CO2 laser treatment
- DEVICE CO2 Laser treatment only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2013-01 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01810484
The ClinicalTrials.gov registry entry for NCT01810484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Ultherapy® treatment only is the first listed.
NCT01810484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01810484 about?
NCT01810484 is a clinical study titled "Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment". Up to 20 subjects will be enrolled. Enrolled subjects will receive one of three study treatments in the abdominal region: Ultherapy® only, Ultherapy® and CO2 laser treatment, or CO2 laser treatment only. Follow-up visit will occur at 14, 90 and 180 days post-treatment. Study images will be obtained ...
What is the current status of trial NCT01810484?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2013-01. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01810484?
The interventions under investigation include: Ultherapy® treatment only (DEVICE), Ultherapy® treatment and CO2 laser treatment (DEVICE), CO2 Laser treatment only (DEVICE).
Who is sponsoring clinical trial NCT01810484?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.